Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Christopher Pan

1PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 10, 2023
Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progression.

Raquel Maeso-Díaz, Kuo Du, Christopher Pan

Pageof 1

Frequent Collaborators

1 joint publications

Raquel Maeso-Díaz

1 joint publications

Kuo Du

1 joint publications

Cynthia D Guy

1 joint publications

Seh Hoon Oh

1 joint publications

Dennis C Ko

1 joint publications

Rajesh K Dutta

1 joint publications

Ji Hye Jun

1 joint publications

Ayako Suzuki

1 joint publications

Manal F Abdelmalek

1 joint publications

Anna Mae Diehl

Frequent Collaborators

1 joint publications

Raquel Maeso-Díaz

1 joint publications

Kuo Du

1 joint publications

Cynthia D Guy

1 joint publications

Seh Hoon Oh

Top Related Videos

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis
08:58

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis

Published on : Mar 11, 2017

16.1K
See more related videos

Top Related Videos

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis
08:58

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis

Published on : Mar 11, 2017

16.1K
See more related videos